Retraction: Sensitizing Estrogen Receptor–negative Breast Cancer Cells to Tamoxifen with OSU-03012, a Novel Celecoxib-derived Phosphoinositide-dependent Protein Kinase-1/Akt Signaling Inhibitor

Retraction: Sensitizing Estrogen Receptor–negative Breast Cancer Cells to Tamoxifen with OSU-03012, a Novel Celecoxib-derived Phosphoinositide-dependent Protein Kinase-1/Akt Signaling Inhibitor

April 03, 2019 0 Comments

This article (1) has been retracted at the request of the editors. Following institutional review by the Ohio State University it was determined that Fig. 4A and B were intentionally falsified by Dr. Ching-Shih Chen. The authors regret any inconveniences or challenges resulting from the publication and subsequent retraction of this article. A copy of this Retraction Notice was sent to the last known email addresses for the authors. Three authors (S.K. Kulp, R.W. Brueggemeier, and C.L. Shapiro) agreed to the retraction; the four remaining authors (S-C. Weng, Y. Kashida, D. Wang, and C-S. Chen) could not be located.



Also in Industry News

Recognizing the signs of overdose and knowing how to respond can save lives
Recognizing the signs of overdose and knowing how to respond can save lives

January 28, 2020 0 Comments

Recognizing the signs of overdose and knowing how to respond can save lives

Read More

China stiffens defences against epidemic as death toll hits 56
China stiffens defences against epidemic as death toll hits 56

January 28, 2020 0 Comments

China stiffens defences against epidemic as death toll hits 56

Read More

Dear Dr. Shaffer. Thanks a lot for posting such a useful information about
Dear Dr. Shaffer. Thanks a lot for posting such a useful information about

January 28, 2020 0 Comments

Dear Dr. Shaffer. Thanks a lot for posting such a useful information about

Read More